| CAT No: | CL-MMLT-020 |
| CAS No: | 1841094-21-0 |
| Mol.F: | C19H16N6O |
| Mol.Wt.: | 344.4 |
| Rel. Cas No: | |
| Chemical Name: | 4-(2-((4-Aminophenyl)amino)pyrimidin-4-yl)-N-(cyanomethyl)benzamide |
| SMILES: | Nc1ccc(Nc2nccc(n2)c3ccc(cc3)C(=O)NCC#N)cc1 |
| Inventory Status: | Custom synthesis |
This impurity is related to Momelotinib Metabolite M17 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Momelotinib Metabolite M17 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:4-(2-((4-Aminophenyl)amino)pyrimidin-4-yl)-N-(cyanomethyl)benzamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Momelotinib Molecular Formula: C19H16N6O
Molecular Weight: 344.4
Storage: Store in a cool, dry place.
| Product Name: | Momelotinib Metabolite M17 |
| CAS No: | 1841094-21-0 |
| Mol.F.: | C19H16N6O |
| Mol.Wt.: | 344.4 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: